Tharimmune, Inc. – NASDAQ:THAR
Tharimmune stock price today
Tharimmune stock price monthly change
Tharimmune stock price quarterly change
Tharimmune key metrics
Market Cap | 3.09M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -6.93 |
Revenue | N/A |
EBITDA | -8.96M |
Income | -8.88M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTharimmune stock price history
Tharimmune stock forecast
Tharimmune financial statements
| Jun 2023 | 0 | -2.33M | |
|---|---|---|---|
| Sep 2023 | 0 | -1.82M | |
| Dec 2023 | 0 | -2.47M | |
| Mar 2024 | 0 | -2.25M |
| 2025 | 0 | -23.88M | |
|---|---|---|---|
| 2026 | 0 | -979.07K | |
| 2027 | 0 | -1.17M | |
| 2028 | 0 | -1.37M |
Analysts Price target
Financials & Ratios estimates
| 2023-11-07 | -1.25 | -2.75 |
|---|---|---|
| 2024-03-21 | -0.05 | -3.75 |
| Jun 2023 | 4599408 | 1.53M | 33.27% |
|---|---|---|---|
| Sep 2023 | 3166951 | 1.41M | 44.52% |
| Dec 2023 | 10946393 | 1.81M | 16.58% |
| Mar 2024 | 8887297 | 1.83M | 20.68% |
| Jun 2023 | -1.51M | 0 | 1.84M |
|---|---|---|---|
| Sep 2023 | -908.96K | 0 | -306.00K |
| Dec 2023 | -1.41M | 0 | 9.66M |
| Mar 2024 | -2.82M | 0 | 317.11K |
Tharimmune alternative data
| Apr 2024 | 2 |
|---|---|
| Jun 2024 | 2 |
| Jul 2024 | 2 |
Tharimmune other data
| Period | Buy | Sel |
|---|---|---|
| Oct 2024 | 12500 | 0 |
| Nov 2024 | 5000 | 0 |
| Dec 2024 | 4600 | 0 |
-
What's the price of Tharimmune stock today?
One share of Tharimmune stock can currently be purchased for approximately $1.22.
-
When is Tharimmune's next earnings date?
Unfortunately, Tharimmune's (THAR) next earnings date is currently unknown.
-
Does Tharimmune pay dividends?
No, Tharimmune does not pay dividends.
-
How much money does Tharimmune make?
Tharimmune has a market capitalization of 3.09M. Tharimmune made a loss 9.32M US dollars in net income (profit) last year or -$3.75 on an earnings per share basis.
-
What is Tharimmune's stock symbol?
Tharimmune, Inc. is traded on the NASDAQ under the ticker symbol "THAR".
-
What is Tharimmune's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Tharimmune?
Shares of Tharimmune can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Tharimmune have?
As Jul 2024, Tharimmune employs 2 workers.
-
When Tharimmune went public?
Tharimmune, Inc. is publicly traded company for more then 3 years since IPO on 12 Jan 2022.
-
What is Tharimmune's official website?
The official website for Tharimmune is tharimmune.com.
-
Where are Tharimmune's headquarters?
Tharimmune is headquartered at 1200 Route 22 East, Bridgewater, NJ.
-
How can i contact Tharimmune?
Tharimmune's mailing address is 1200 Route 22 East, Bridgewater, NJ and company can be reached via phone at +90 89553140.
Tharimmune company profile:
Tharimmune, Inc.
tharimmune.comNASDAQ
2
Biotechnology
Healthcare
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.
Bridgewater, NJ 08807
CIK: 0001861657
ISIN: US4327052001
:
